279
Participants
Start Date
October 31, 2011
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Standard ART
Standard Ugandan 3-drug antiretroviral therapy regimen consistent with current practices
Study-Provided ART
"Study provided drugs:~1. Truvada® (one tablet PO daily of fixed dose combination consisting of tenofovir disoproxyl fumarate \[TDF\] and emtricitabine \[FTC\]) PLUS~2. Efavirenz \[EFV\]"
Bwizibwera Level IV Health Center, Bwizibwera
Makerere University Joint AIDS Program
OTHER
Infectious Diseases Research Collaboration, Uganda
OTHER
Makerere University
OTHER
University of California, San Francisco
OTHER